Skip to content
Tens of thousands of happy customersFree shipping over $4930-day money-back guaranteeEvery batch tested by a DEA-registered lab

Terp Journal Club #1: The Johns Hopkins Limonene Trial

Welcome to Journal Club, a new Terp School series where we read terpene research so you do not have to, and tell you honestly what it shows and what it does not. No cherry-picking, no miracle framing. First up: the study that put limonene on the map.

The study

In 2024, researchers at Johns Hopkins, led by Tory Spindle, published a placebo-controlled, double-blind trial in Drug and Alcohol Dependence. Healthy adults who use cannabis came into the lab multiple times and inhaled vaporized THC alone, THC plus d-limonene, limonene alone, or placebo, without knowing which was which. That design matters: most terpene claims trace back to petri dishes or rodents, and this was actual humans under controlled conditions.

What it found

The headline result: when limonene was vaporized alongside THC, participants reported feeling less anxious and paranoid from the THC than with THC alone, and the effect grew at the higher limonene dose. Limonene by itself did essentially nothing measurable, and it did not change how intoxicated people felt overall. The researchers framed this as early evidence for the entourage idea that the compounds riding along with THC shape the character of the experience.

What it cannot tell you

Here is the part most coverage skips, and the part we care about most:

  • It was small, roughly twenty people, one lab, one study. Science treats that as a promising start, not a settled fact.
  • It studied vaporized limonene taken with THC. It says nothing direct about eating limonene, or about limonene without THC in the picture.
  • It measured how people said they felt during a THC experience. It was not a study of any consumer product, and certainly not ours.

So we will not tell you a chew does what this trial describes. What the study genuinely shows is why terpene profiles are worth paying attention to at all: the minor compounds in a strain are not decoration, and serious researchers now study them in humans.

Why we find it exciting anyway

MONDAYS exists on a simple conviction: strains are defined by their terpenes, and the industry ignored them for years while chasing potency. A rigorous human trial treating a single terpene as worthy of placebo-controlled study is the scientific world catching up to that conviction. Limonene is the bright citrus note in lemon rind, and it leads or co-leads several of our profiles; you can see exactly how much is in every chew on each product page, down to the milligram, straight from an ISO 17025 lab profile.

Want to go deeper? Meet the compound itself on our limonene page, see it at 19% of the profile in Go-Go Bananas, or browse every strain we carry with the full chart open on each page.

Source: Spindle et al., "Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol," Drug and Alcohol Dependence, 2024. Research summaries describe studies of compounds at their own doses, not this product.

Class dismissed. See you next Monday.

Previous Post Next Post

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This product contains a non-intoxicating Cannabis Sativa L./Industrial Hemp derived ingredient.